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This Special Issue of Insurance: Mathematics and Economics contains 16 
contributions to the academic literature all dealing with longevity risk and capital 
markets. Draft versions of the papers were presented at Longevity 11: The Eleventh 
International Longevity Risk and Capital Markets Solutions Conference that was held 
in Lyon, France on 8-9 September 2015. It was hosted by Institut de Science Financière 
et d'Assurance (ISFA), Université Lyon 1, Lyon, and co-hosted by Laboratoire de 
Science Financière et d'Assurances, Lyon; Laboratoire de Probabilités et Modéles 
Aléatoires, Université Pierre et Marie Curie, Paris; Pensions Institute, Cass Business 
School, City University of London, UK; and the LoLitA (Longevity with Lifestyle 
Adjustments) ANR research project team. It was sponsored by Prudential Financial, 
SCOR, Société Générale Corporate and Investment Banking, the Society of Actuaries 
(SOA), EY, Milliman, Reinsurance Group of America, Aon Benfield, Guy Carpenter, 
PRIM’ACT, and SINALYS.   
 
Longevity risk and related capital market solutions have grown increasingly important 
in recent years, both in academic research and in the market we refer to as the new Life 
Market, i.e., the capital market that trades longevity-linked assets and liabilities.1 
Mortality improvements around the world are putting more and more pressure on 
governments, pension funds, life insurance companies, as well as individuals, to deal 
with the longevity risk they face. At the same time, capital markets can, in principle, 
provide vehicles to hedge longevity risk effectively and transfer the risk from those 
unwilling or unable to manage it to those willing to invest in this risk in exchange for 
appropriate risk-adjusted returns or to those who have a counterpoising risk that 
longevity risk can hedge, e.g., life offices and reinsurers with mortality risk on their 
books. Many new investment products have been created both by the 
insurance/reinsurance industry and by the capital markets. Mortality catastrophe bonds 
are an example of a successful insurance-linked security. Some new innovative capital 
market solutions for transferring longevity risk include longevity (or survivor) bonds, 
longevity (or survivor) swaps and mortality (or q-) forward contracts. The aim of the 
International Longevity Risk and Capital Markets Solutions Conferences is to bring 
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together academics and practitioners from all over the world to discuss and analyze 
these exciting new developments.  
 
The conferences have closely followed the developments in the market. The first 
conference (L1) was held at Cass Business School in London in February 2005. This 
conference was prompted by the announcement of the Swiss Re mortality catastrophe 
bond in December 2003 and the European Investment Bank/BNP Paribas/PartnerRe 
longevity bond in November 2004.  
 
The second conference (L2) was held in April 2006 in Chicago and hosted by the Katie 
School at Illinois State University. 2  Since L1, there have been further issues of 
mortality catastrophe bonds, as well as the release of the Credit Suisse Longevity Index. 
In the UK, new life companies backed by global investment banks and private equity 
firms were setting up for the express purpose of buying out the defined benefit pension 
liabilities of UK corporations. Goldman Sachs announced it was setting up such a 
buy-out company itself (Rothesay Life) because the issue of pension liabilities was 
beginning to impede its mergers and acquisitions activities.3 It decided that the best 
way of dealing with pension liabilities was to remove them altogether from the balance 
sheets of takeover targets. So there was firm evidence that a new global market in 
longevity risk transference had been established. However, as with many other 
economic activities, not all progress follows a smooth path. The EIB/BNP/PartnerRe 
longevity bond did not attract sufficient investor interest and was withdrawn in late 
2005. A great deal, however, was learned from this failed issue about the conditions and 
requirements needed to launch a successful capital market instrument.  
 
The third conference (L3) was held in Taipei, Taiwan on 20-21 July 2007. It was 
hosted by National Chengchi University.4  It was decided to hold L3 in the Far East, 
not only to reflect the growing importance of Asia in the global economy, but also to 
recognize the fact that population ageing and longevity risk are problems that affect 
all parts of the world and that what we need is a global approach to solving these 
problems. 5  Since the Chicago conference, there had been a number of new 
developments, including: the release of the LifeMetrics Indices covering England & 
Wales, the US, Holland and Germany in March 2007 by J.P. Morgan, the Pensions 
Institute and Towers Watson;6 the world's first publicly announced longevity swap 
                                                 
2  The conference proceedings for L2 were published in the December 2006 issue of the Journal of Risk 
and Insurance. 
3 With a buy-out, an insurance company buys out the liabilities of a pension scheme which is paid for 
with the pension scheme assets and a loan if the scheme is in deficit at the time. Both the pension scheme 
assets and liabilities are removed from the corporate sponsor’s balance sheet. Each member has a 
personal annuity from the insurer who takes over responsibility for paying the pensions. This contrasts 
with a buy-in, where the liabilities remain on the sponsor’s balance sheet, but the scheme buys bulk 
purchase annuities (BPAs) from an insurance company and pays members’ pensions from the annuity 
payments it receives from the insurer. The BPA is an asset of the scheme, not the members. The world’s 
first specialist buy-out company was Paternoster which was established in the UK in 2006. This was 
closely followed by the Pension Insurance Corporation (also in 2006) and Lucida and Rothesay Life 
(both 2007). Paternoster executed the first buy-out in November 2006 of the Cuthbert Heath Family Plan, 
a small UK plan with just 33 members. It also executed the first pensioner buy-in with Hunting PLC in 
January 2007. Paternoster was bought by Rothesay Life in 2011. 
4  The conference proceedings for L3 were published in the Fall 2008 issue of the Asia-Pacific Journal 
of Risk and Insurance. 
5  In fact, Asia has the world’s largest and fastest growing ageing population (United Nations, 2007). 
6 www.lifemetrics.com 
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between Swiss Re and the UK life office Friends' Provident in April 2007 (although 
this was structured as an insurance or indemnification contract rather than a capital 
market transaction). 
 
Since the Taiwan conference, there were further developments in the capital markets. 
In December 2007, Goldman Sachs launched a monthly index suitable for trading life 
settlements.7 The index, QxX.LS, was based on a pool of 46,290 anonymized US lives 
over the age of 65 from a database of life policy sellers assessed by the medical 
underwriter AVS. In 2008, Institutional Life Services (ILS) and Institutional Life 
Administration (ILA), a life settlements trading platform and clearing house, were 
launched by Goldman Sachs, Genworth Financial, and National Financial Partners. ILS 
and ILA were designed to modernize dealing in life settlements and meet the needs of 
consumers by ensuring permanent anonymity of the insured and of the capital markets 
by providing a central clearing house for onward distribution of life settlement assets, 
whether individually or in structured form.8 
 
Xpect Age and Cohort Indices were launched in March 2008 by Deutsche Börse. These 
indices cover, respectively, life expectancy at different ages and survival rates for given 
cohorts of lives in Germany and its regions, Holland and England & Wales.  
 
The world’s first capital market derivative transaction, a q-forward contract9 between 
J. P. Morgan and the UK pension fund buy-out company Lucida, took place in January 
2008. The world’s first capital market longevity swap was executed in July 2008. 
Canada Life hedged £500m of its UK-based annuity book (purchased from the defunct 
UK life insurer Equitable Life). This was a 40-year swap customized to the insurer’s 
longevity exposure to 125,000 annuitants. The longevity risk was fully transferred to 
investors, which included hedge funds and insurance-linked securities (ILS) funds. J. P. 
Morgan acted as the intermediary and assumes counter-party credit risk. Forty eight 
longevity swaps were completed in the United Kingdom between 2007 and 2016, 
valued at £75bn and covering 13 insurance companies’ annuity and buy-out books, 22 
private sector pension funds, and one local authority pension fund (some of which 
executed more than one swap).10 In August 2011, ITV, the UK’s largest commercial 
TV producer, completed a £1.7bn bespoke longevity swap with Credit Suisse for its 
£2.2bn pension plan: the cost of the swap is reported as £50m (3% of the swap value). 
The largest to date, covering £16bn of pension liabilities, was the longevity swap for 
the British Telecom (BT) Pension Scheme, arranged by the Prudential Insurance Co of 
America in July 2014. In February 2010, Mercer launched a pension buy-out index for 
the UK to track the cost charged by insurance companies to buy out corporate pension 
liabilities: at the time of launch, the cost was some 44% higher than the accounting 
value of the liabilities which highlighted the attraction of using cheaper alternatives, 
such as longevity swaps. 
 
                                                 
7  Life settlements are traded life policies. In April 2007, the Institutional Life Markets Association 
started in New York, as the dedicated institutional trade body for the life settlements industry. 
8  In 2010, National Financial Partners became the sole owner of ILS/ILA. 
9  Coughlan et al. (2007). 
10 www.artemis.bm/library/longevity_swaps_risk_transfers.html 
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The fourth conference (L4) was held in Amsterdam on 25-26 September 2008. It was 
hosted by Netspar and the Pensions Institute.11 In 2008, Credit Suisse initiated a 
longevity swap with Centurion Fund Managers, whereby Centurion acquired a 
portfolio of synthetic (i.e., simulated) life policies, based on a longevity index built by 
Credit Suisse. In 2009, survivor swaps began to be offered to the market based on 
Deutsche Börse’s Xpect Cohort Indices.  
 
The fifth conference (L5) was held in New York on 25-26 September 2009.12 On 1 
February 2010, the Life and Longevity Markets Association (LLMA) 13  was 
established in London. Its current members are Aviva, AXA, Deutsche Bank, J.P. 
Morgan, Morgan Stanley, Prudential PLC, and Swiss Re. LLMA was formed to 
promote the development of a liquid market in longevity- and mortality-related risks. 
This market is related to the ILS market and is also similar to other markets with trend 
risks, e.g., the market in inflation-linked securities and derivatives. LLMA aims to 
support the development of consistent standards, methodologies and benchmarks to 
help build a liquid trading market needed to support the future demand for longevity 
protection by insurers and pension funds. In April 2011, the LifeMetrics indices were 
transferred to LLMA with the aim of establishing a global benchmark for trading 
longevity and mortality risk. 
 
The sixth conference (L6) was held in Sydney on 9-10 September 2010.14 In 
December 2010, building on its successful mortality catastrophe Vita bonds and 
taking into account the lessons learned from the failed EIB bond, Swiss Re launched a 
series of eight-year longevity-based ILS notes valued at $50m. To do this, it used a 
special purpose vehicle, Kortis Capital, based in the Cayman Islands. As with the 
mortality bonds, the longevity notes are designed to hedge Swiss Re's own exposure 
to mortality and longevity risk. In particular, holders of the notes are exposed to an 
increase in the spread between mortality improvements in 75-85-year-old English & 
Welsh males and 55-65-year-old US males, indicating that Swiss Re has life 
insurance (mortality risk) exposure in the US and pension (longevity risk) exposure in 
the UK. 
 
In January 2011, the Irish government announced that it would issue bonds that allow 
the creation of sovereign annuities. This followed a request from the Irish Association 
of Pension Funds and the Society of Actuaries in Ireland. If the bonds are purchased 
by Irish pension funds, this will have a beneficial effect on the way in which the Irish 
funding standard values pension liabilities. On account of a statutory deadline to 
submit a deficit repair plan, 2013 was a record year for bulk annuity transactions in 
Ireland with sovereign annuities being used in a significant number of transactions. 
 
The world’s first longevity swap for non-pensioners (i.e., for active and deferred 
members of a pension plan) took place in January 2011, when J. P. Morgan executed a 
£70m 10-year q-forward contract with the Pall (UK) pension fund. This was a value 
                                                 
11  The conference proceedings for L4 were published in the February 2010 issue of Insurance: 
Mathematics and Economics. 
12   The conference proceedings for L5 were published in the North American Actuarial Journal 
(Volume 15, Number 2, 2011). 
13 www.llma.org 
14  The conference proceedings for L6 were published in the October 2011 issue of Geneva Papers on 
Risk and Insurance - Issues and Practice. 
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swap designed to hedge the longevity risk in the value of Pall’s pension liabilities, 
rather than the longevity risk in its pension payments as in the case of cash flow swaps 
which have been the majority of the swaps that have so far taken place. Longevity risk 
prior to retirement is all valuation risk: there is no cash flow risk and most of the risk 
lies in the forecasts of mortality improvements. Further, the longevity exposure of 
deferreds is not well defined as a result of the options that plan members have, e.g., 
lump sum commutation options, early retirement options, and the options to increase 
spouses’ benefits at the expense of members’ benefits.  
 
In 2011, Willis Towers Watson (WTW) introduced the pension captive structure. A 
scheme executes a pensioner buy-in with a standard insurer, but then the insurer 
reinsures the buy-in back to a captive owned by the sponsor. Captives can provide a 
cost-effective solution compared with either a traditional buy-in or directly running 
the scheme over the longer term. This is because there can be a more efficient 
blending of investment management services with insurance, combined with a more 
effective disaggregation of risks and hence a more capital-efficient management of 
those risks. The first scheme to use it was Coca Cola.15 
 
In December 2011, Long Acre Life entered the market to offer cheaper pension 
insurance solutions to larger schemes with liabilities above £500 million. Under these 
solutions companies offload their pension plans to an insurance vehicle in which they 
also invest and so share the profits along with external investors: the target return is 
15% p.a. In January 2012, Legal & General (L&G) began offering longevity insurance 
(in the form of deferred buy-ins) for the 1,000 smaller schemes with liabilities in the 
range £50-£250 million. In February 2012, Punter Southall, a medium-sized UK 
pension consultant, adopted PensionsFirst’s pension liability and risk management 
software (PFaroe) to automate the production of actuarial valuations and hence cut 
costs for pension plans, particularly small ones. In the same month, another 
medium-sized pension consultant, Hymans Roberton, launched a pension de-risking 
monitoring service which compares the costs of a full buy-out with the costs of a buy-in 
covering only pensioner members and the costs of a longevity swap.   
 
In April 2011, the International Society of Life Settlement Professionals (ISLSP)16 
formed a life settlement and derivatives committee and announced that it was 
developing a life settlement index. The purpose of the index is to benchmark net asset 
values in life settlements trading. Investors need a reliable benchmark to measure 
performance and the index will help turn US life insurance policies into a tradable 
asset class according to ISLSP. The calculation agent for the index is AA Partners. 
 
The first pension risk transfers deals outside the UK took place in 2009-11. The first 
buy-in deal outside the UK took place in 2009 in Canada; it was arranged by Sun Life 
Financial and valued at C$50m. The first buy-in deal in Europe took place in December 
2010 between the Dutch food manufacturer Hero and the Dutch insurer Aegon (€44m). 
The first buy-in deal in the US took place in May 2011 between Hickory Springs 
Manufacturing Company and Prudential (US) ($75m). The first buy-out deal outside 
the UK was announced in May 2011 and involved the C$2.5bn Nortel pension plan in 
                                                 
15 Willis Towers Watson (2017) Key themes in the longevity hedging and bulk annuity market: 
De-risking report 2017. 
16 www.islsp.org 
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Canada. In September 2011, CAMRADATA Analytical Services launched a new 
pension risk transfer (PRT) database for US pension plans. The database provides 
insurance company organisational information, pension buy-in and buy-out product 
fact sheets and screening tools, pricing data, up-to-date information on each PRT 
provider's financial strength and relevant industry research. Users can request pension 
buy-in and buy-out quotes directly from providers, including American General Life 
Companies, MetLife, Pacific Life, Principal Financial Group, Prudential (US), 
Transamerica and United of Omaha. 
 
The first international longevity reinsurance transaction took place in June 2011 
between Rothesay Life (UK) and Prudential (US) and was valued at £100m. The first 
life book reinsurance swap since the Global Financial Crisis took place in June 2011 
between Atlanticlux and institutional investors and was valued at €60m.  
 
The seventh conference (L7) was held at the House of Finance, Goethe University, 
Frankfurt, Germany on 8-9 September 2011.17  
 
In February 2012, Deutsche Bank executed a massive €12 billion index-based 
longevity solution for Aegon in the Netherlands. This solution was based on Dutch 
population data and enabled Aegon to hedge the liabilities associated with a portion of 
its annuity book. Because the swap is out of the money, the amount of longevity risk 
actually transferred is far less than that suggested by the €12 billion notional amount. 
Nonetheless, the key driver for this transaction from Aegon’s point of view was the 
reduction in economic capital it achieved. Most of the longevity risk has been passed to 
investors in the form of private bonds and swaps.   
 
In June 2012, General Motors Co. (GM) announced a huge deal to transfer up to $26 
billion of pension obligations to Prudential (US). This is by far the largest ever 
longevity risk transfer deal globally. The transaction is effectively a partial pension 
buy-out involving the purchase of a group annuity contract for GM’s salaried retirees 
who retired before 1 December 2011 and refused a lump sum offer in 2012. To the 
extent retirees accepted a lump sum payment in lieu of future pension payments, the 
longevity risk was transferred directly to the retiree.18 The deal was classified as a 
partial buy-out rather than a buy-in because it involved the settlement of the obligation. 
In other words, the portion of the liabilities associated with the annuity contract will no 
longer be GM’s obligation. Moreover, in contrast to a buy-in, the annuity contract will 
not be an asset of the pension plan, but instead an asset of the retirees. In October 2012, 
GM did a $3.6 billion buy-out of the pension obligations of its white-collar retirees. 
Also in October 2012, Verizon Communications executed a $7.5 billion bulk annuity 
buy-in with Prudential (US). The buy-out deals in the U.S. in 2012 amounted to $36 
billion.  
 
The buy-outs for private sector pension plans had all involved plans that were closed to 
future accrual. However, in March 2012, PIC executed the first buy-out of a plan open 
to future accrual: the sponsoring employer, the high-tech manufacturer Denso, will pay 
PIC an annual premium based on the number of active members and their salaries, but 
PIC will assume all the liabilities. PIC had previously conducted an innovative buy-in 
                                                 
17 The conference proceedings for L7 were published in the September 2013 issue of the Journal of Risk 
and Insurance. 
18 In fact, the lump sum is only being offered to limited cohorts of plan members. 
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in May 2011 with the London Stock Exchange’s defined benefit pension plan which not 
only insured current pensioner members, but will also automatically insure active and 
deferred members when they reach retirement.   
 
The eighth conference (L8) was held at the University of Waterloo, Ontario, Canada on 
7-8 September 2012.19 In June of that year, the OECD released the first edition of 
Pensions Outlook. This called on governments to kick-start the creation of a functional 
longevity risk market and consider issuing longevity bonds, without which the annuity 
market is unlikely to work well. In September 2012, Swiss Re released a report entitled 
A mature market: Building a capital market for longevity risk. The report called for the 
development of a capital market for longevity risk. It said that ‘Society's longevity risk 
could be tackled to a greater extent if reinsurers were able to expand their capacity, and 
this could be done by encouraging capital market investors to invest in longevity 
instruments. …The main challenges include achieving transparency in measuring the 
risk and potential liability, building a secondary market, increasing investor education, 
providing the right level of return and regulation’.20  
 
In December 2012, the enhanced buy-in market opened for business in the UK for 
defined benefit pension schemes. An enhanced buy-in is where a scheme’s trustees buy 
a group annuity as in investment of the scheme, where some or all of the members 
covered by the policy are medically underwritten. Medical underwriting, which is now 
commonplace in the individual annuity market (i.e., in relation to defined contribution 
pensions), has the potential to reduce the cost to the scheme of the longevity hedge 
compared with standard annuities, on the grounds that certain members might have 
lower than average life expectancy as a result of their lifestyle or some serious 
life-shortening illness. The market was introduced by two specialist insurers, 
Partnership and Just Retirement, but other larger insurers followed, e.g., L&G which 
offers a Large Individual Defined Benefit Annuity (LIBDA) service. 
 
In February 2013, the first medically underwritten bulk annuity (MUBA) transaction 
was executed in the UK by Partnership.21 This involved each member filling in a 
medical questionnaire in order to get a more accurate assessment of their life 
expectancy based on their medical history or lifestyle. This was particularly useful in 
the case of ‘top slicing’, where scheme trustees insure the pensioners (who will 
typically be the company directors) with the largest liabilities and who therefore 
represent a disproportionate risk concentration for the scheme. In December 2014, 
Partnership executed a £206m medically underwritten bulk annuity transaction with a 
top slicing arrangement for the £2bn Taylor Wimpey pension scheme. L&G transacted 
a £230m medically-underwritten buy-in in December 2015 with the Kingfisher 
Pension Scheme, covering 149 high-value members. The process of collecting medical 
information has been streamlined in recent years using third-party medical data 
collectors, such as MorganAsh, Age Partnership and Aon’s AHEAD platform – all of 
which perform MUMS (medically underwritten mortality studies). It is expected that 
the share of medically underwritten de-risking deals will increase significantly over the 
next few years in the UK, with new business more than doubling from £540m in 2014 
                                                 
19 The conference proceedings for L8 were published in the North American Actuarial Journal (Volume 
18(1), 2014). 
20 http://www.swissre.com/media/news_releases/nr_20120924_capital_market_longevity.html 
21 Harrison and Blake (2013). 
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to £1,200m in 2015, i.e., from 5% to 12.5% of the market.22 In April 2016, the two 
largest UK medical underwriters, Partnership and Just Retirement – which both entered 
the market in 2012 – merged to form Just valued at £16bn. In December 2016, Just 
executed a £110m medically underwritten buy-in with the Land Securities Group of 
Companies' defined benefit pension fund. 
In April 2013, L&G reported its first non-UK deal, the buy-out of a €136m annuity 
book from New Ireland Life. In June 2013, the Canadian Wheat Board executed a 
C$150m pension buy-in from Sun Life of Canada, involving inflation-linked annuities, 
while in March 2014, an unnamed Canadian company purchased C$500m of annuities 
from an insurer reported to be Industrial Alliance, making it the largest ever Canadian 
pension risk transfer deal to date.  
In August 2013, Numerix, a risk management and derivatives valuation company, 
introduced a new asset class called ‘life’ on its risk modelling platform (in addition to 
equities, bonds and commodities). In November 2013, SPX Corp. of Charlotte, NC, 
purchased a buy-out contract with Massachusetts Mutual Life Insurance Co as part of a 
deal that moved $800m in pension obligations off SPX’s balance sheet.  
The ninth conference (L9) was held in Beijing, China on 6-7 September 2013.23 
In September 2013, UK consultant Barnett Waddingham launched an insurer financial 
strength review service which provides information on an insurer’s structure, solvency 
position, credit rating, and key risk’s in their business model. This service was 
introduced in response to concerns about the financial strength of some buy-out 
insurers. 
In November 2013, Deutsche Bank introduced the Longevity Experience Option 
(LEO). It is structured as an out-of-the-money call option spread on 10-year forward 
survival rates and has a 10-year maturity. The survival rates will be based on males and 
females in five-year age cohorts (between 50 to 79) derived from the England & Wales 
and Netherlands LLMA longevity indices. LEOs will be traded over-the-counter under 
a standard ISDA24 contract. They allow longevity risk to be transferred between 
pension funds, insurance companies and investors. They are intended to provide a 
cheaper and more liquid alternative to bespoke longevity swaps which are generally 
costly and time consuming to implement. Purchasers of the option spread, such as a 
pension fund, will gain if realised survival rates are higher than the forward rates, but 
the gains will be limited, thereby providing some comfort to the investors providing the 
longevity hedge. The 10-year maturity is the maximum that Deutsche Bank believes 
investors will tolerate in the current stage in the development of a market in longevity 
risk transfers. It was reported that Deutsche Bank executed its first LEO transaction 
with an ILS fund in January 2014.  
In December 2013, Aegon executed a second longevity risk transfer to capital markets 
investors and reinsurers, including SCOR. Société Générale was the intermediary in the 
                                                 
22 Hunt and Blake (2016). 
23  The conference proceedings for L9 were published in Insurance: Mathematics and Economics 
(Volume 63 (July), 2015). 
24 International Swaps and Derivatives Association. 
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€1.4 billion deal and Risk Management Solutions (RMS) was the modelling agent.25 
Also in December 2013, the Joint Forum reported on the results of its consultation on 
the longevity risk transfer market. It concluded that this market is not yet big enough to 
raise systemic concerns, but ‘their massive potential size and growing interest from 
investment banks to mobilize this risk make it important to ensure that these markets 
are safe, both on a prudential and systemic level’ (Joint Forum (2013, p.2)).  
In February 2014, the Mercer Global Pension Buy-out Index was introduced. It shows 
the benchmark prices of 18 independent third-party insurers in the four countries with 
the greatest interest in buying out defined benefit liabilities: UK, US, Canada and 
Ireland. Costs were highest in the UK where the cost of insuring £100m of pension 
liabilities was 123% of the accounting value of the liabilities – equivalent to £32 per £1 
p.a. of pension.26 The comparable costs in Ireland, the US and Canada were 117%, 
108.5% and 105%, respectively.  The higher cost in the UK is in part due to the greater 
degree of inflation uprating of pensions in payment in the UK compared with the other 
countries. The difference between the US and Canada is explained by the use of 
different mortality tables. Rising interest rates and equity markets will lower funding 
deficits and hence lead to lower buy-out costs in future, especially in the US.27  
 
In July 2014, Mercer and Zurich launched Streamlined Longevity Solution, a longevity 
swap hedge for smaller pension schemes with liabilities above £50m. This is part of a 
new Mercer SmartDB service which provides bespoke longevity de-risking solutions 
and involves a panel of reinsurers led by Zurich. It reduces the costs by having 
standardized processes for quantifying the longevity risk in each pension scheme. The 
first deal, valued at £90m, was transacted with an unnamed UK pension scheme in 
December 2015. A second deal – this time with the UK pension scheme of the Italian 
tyre company Pirelli – was executed in August 2016 for £600m. 
 
The tenth conference (L10) was held at Universidad Diego Portales in Santiago, Chile 
on 3-4 September 2014.28 
 
In December 2014, WTW launched Longevity Direct, an off-shore longevity swap 
hedging service that gives medium-sized pension schemes with liabilities between 
£1-3bn direct access to the reinsurance market, via its own cell (or captive) insurance 
company. This allows schemes to bypass insurers and investment banks – the 
traditional de-risking intermediaries – and significantly reduces transactions costs and 
completion times, while still getting the best possible reinsurance pricing. The first 
reported transaction on the Longevity Direct platform was the £1.5bn longevity swap 
executed by the Merchant Navy Officers Pension Fund (MNOPF) in January 2015 
which was insured by MNOPF IC, a newly established cell insurance company based in 
Guernsey, and then reinsured with Pacific Life Re. In February 2015, PwC launched a 
similar off-shore longevity swap service for pension schemes as small as £250m. It uses 
a Guernsey-based incorporated cell company called Iccaria, established by Artex Risk 
                                                 
25 RMS has developed a Longevity Model which was built by a team with expertise in epidemiology, 
mathematical biology, genetics, biostatistics, financial engineering, public health policy and medical 
science. RMS describes its model as a ‘structural meta-model of geroscience advancement’. 
26 Towers Watson (2015) Corporate Briefing, April. 
27 Mercer uses the RMS Longevity Risk Model. 
28 The conference proceedings for L10 were published in the Journal of Risk and Insurance (Volume 
84(S1), April 2017). 
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Solutions, to pass longevity risk directly on to reinsurers. The arrangement is fully 
collateralized and each scheme owns a cell within Iccaria which again avoids the costs 
of dealing with insurer and investment bank intermediaries. WTW introduced the first 
tracking software system to follow live insurer pricing, sending alerts when a scheme 
closes in on a target price. 
 
There is evidence of increasing demand from reinsurance companies for exposure to 
large books of pension annuity business to offset the risk in their books of life 
insurance.29 For example, in July 2014, Warren Buffett’s Berkshire Hathaway agreed 
to a £780m quota-reinsurance deal with the Pension Insurance Corporation. Similarly, 
in August 2014, Delta Lloyd executed a €12bn longevity swap with RGA Re, while 
AXA France executed a €750m longevity swap with Hannover Re.  
 
In March 2014, the UK insurer L&G announced the biggest single buy-out in the UK to 
date when it took on £3bn of assets and liabilities from ICI’s pension scheme, a 
subsidiary of AkzoNobel. The deal uses ‘umbrella’ contracts which enables the scheme 
to add further liabilities onto the original contract. 30  In December 2014, L&G 
announced the largest ever UK buy-in valued at £2.5bn with US manufacturer TRW.  
In fact, in 2014, TRW became the first global corporation to simultaneously complete 
three de-risking transactions in three different countries: the UK, the US and Canada. 
Also in 2014, the Aviva Staff Pension Scheme completed the first limited recourse 
longevity swap, involving £5 billion in liabilities and 19,000 participants, Around 
£13bn of bulk annuity deals were executed in the UK in 2014, the largest volume of 
business since the de-risking market began in 2006 and beating the previous best year 
of 2008, just before the Global Financial Crisis, when £7.9bn of deals were completed. 
The total volume of de-risking deals in the UK in 2014 alone (covering buy-outs, 
buy-ins and longevity swaps) was £35bn, a significant proportion of which is accounted 
for by the £16bn BT longevity swap. To complete the transaction, the BT scheme 
created its own captive insurer located in Guernsey, which insured the longevity risk. 
The captive insurer then reinsured the risk in a fully collateralized arrangement. The 
scheme’s immense scale and advanced capabilities helped it to become the first to 
execute such a transaction. Captive and limited recourse transactions have dominated 
the market since 2014. 
 
In response to the announcement by the UK finance minister (George Osborne) in his 
Budget Speech on 19 April 2014, that UK pension scheme members no longer needed 
to buy annuities when they retired (which resulted in an immediate fall in annuity sales 
of more than 50%), a number of traditional annuity providers, including Scottish 
Widows, reported that they were considering entering the bulk annuity market. 
In November 2014, the Longevity Basis Risk Working Group (2014) of the Institute & 
Faculty of Actuaries (IFoA) and LLMA published Longevity Basis Risk: A 
Methodology for Assessing Basis Risk. This study develops a new framework for 
insurers and pension schemes to assess longevity basis risk. This, in turn, will enable 
                                                 
29 The biggest buyers of longevity risk at the present time are global reinsurers. Nevertheless, according 
to Hannover Re: “The number of risk-takers is limited and there is no unlimited capacity in the market 
for taking on longevity risk. The increasing worldwide demand for longevity cover will challenge the 
capacity for securing longevity risk” (quoted in Punter Southall (2015) De-risking Bulletin, March). 
30 By October 2016, the ICI scheme had completed 11 such deals – with L&G, Prudential (UK) and 
Scottish Widows – with a total value of £8bn, saving the parent company over £100mn in costs. 
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simpler, more standardized and easier to execute index-based longevity swaps to be 
implemented. Index-based longevity swaps allow insurers and pension schemes to 
offset the systemic risk of increased liabilities resulting from members living longer 
than expected. It had hitherto been difficult to assess how effectively an index-based 
longevity swap could reduce the longevity risk in a particular insurance book or 
pension scheme. The methodology they developed is applicable to both large schemes 
(which are able to use their own data in their models) and smaller schemes (by 
capturing demographic differences such as socio-economic class and deprivation). In 
May 2016, a follow-up study – to be carried out by Macquarie University, Australian 
National University, Mercer Australia, and the University of Waterloo in Ontario – was 
announced. The purpose is to design a ‘readily applicable methodology’ for use with 
longevity risk indices: ‘Such indices are often used in pension benefits and annuitant 
liabilities, as well as in providing actuaries with key data, …but the problem of the 
existence of basis risk remains unsolved.’ 
In March 2015, the UK government announced that it would introduce a new 
competitive corporate tax structure to allow Insurance Linked Securities to be 
domiciled in the UK. In May 2015, Rothesay Life, the insurance company owned by 
Goldman Sachs, bought out the liabilities of Lehman Brothers' UK pension scheme for 
£675m, thereby securing the pensions of former employees of the company associated 
with the beginning of the Global Financial Crisis. In April 2016, Rothesay Life bought 
two-thirds of Aegon’s UK annuity book – representing 187,000 policy holders – for 
£6bn, bringing total assets under management to £20bn and total lives assured to over 
400,000. This was the first substantial annuity transfer since the introduction of 
Solvency II in January 2016. This new solvency regime for EU-based insurers 
increased capital requirements and has reduced the attractiveness of annuities as a 
business line for certain insurers and raised buy-out prices by 5-7%.31  Deferred 
members are the most expensive to insure, since their life expectancy is the most 
                                                 
31 Financial News, 28 March–3 April 2016. The main objective of Solvency II is to value all assets and 
liabilities on a market-consistent basis and to ensure that the regulatory capital that insurance companies 
hold reflects all the risks on their balance sheets. The capital needs to be sufficient to guarantee that an 
insurance company can survived a series of prescribed stressed events over the course of one year with a 
99.5% probability. One example of a stress is a sudden 20% reduction in mortality rates across all ages: 
for a 65-year old UK male, this corresponds to a 2 year increase in life expectancy or a 7% increase in 
pension liabilities. A consequence of the market-consistent approach is that both assets and liabilities are 
more prone to market volatility, although with long-term liabilities, such as annuities and buy-outs, 
short-term asset price volatility can be partially offset by ‘matching adjustments’. The insurer would 
need to allocate a specific pool of assets to the liability, where the assets are selected to match the 
cash-flow characteristics of the liability. The assets need to be matched for the entire term of the liability, 
in which case the liability can be valued using a higher discount rate than prescribed by the regulator 
(European Insurance and Occupational Pensions Authority, EIOPA), resulting in the insurer holding 
lower ‘own funds’ to back the liability. However, because of longevity risk, the asset match can never be 
perfect and this has the effect of raising the level of own funds. A particular example is non-pensioner 
members of pension schemes who have greater longevity risk than pensioner members, leading to a 
lower adjusted discount rate. There is also greater optionality with non-pensioner members (such as early 
retirement and commutation options) and this also reduces the discount rate and, by raising the level of 
own funds, increases the cost of providing deferred annuities to the pension scheme or buying out this 
segment of the pension scheme. Insurance companies increasingly invest in long-term assets like 
infrastructure and reverse mortgages to reduce asset price volatility, and in corporate bonds to benefit 
from the credit and illiquidity premia embodied in their higher returns compared with government bonds. 
They also make increasing use of reinsurance to reduce the volatility of liabilities. 
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uncertain, given their younger ages – yet they comprise 45% of the membership of UK 
schemes (i.e., 4.9m members).32 
 
The largest buy-out to date in the UK was for the Philips Pension Fund which in 
November 2015 completed a full buy-out of the pension benefits of 26,000 members 
valued at £2.4bn with the Pension Insurance Corporation. An interesting feature of 
this deal was that a buy-out was combined with a longevity hedge. The longevity risk 
was simultaneously reinsured with Hannover Re. Another interesting feature was that 
it covered both retired and deferred members, with the latter’s benefits valued at 
£1bn. 
 
An important new longevity-linked product that took off in the UK in 2015 was the 
lifetime mortgage (also known as equity release or reverse mortgage). This allows 
individuals to release equity in their homes to fund their retirement without 
downsizing. L&G, for example, set up L&G Home Finance for this purpose and in its 
first year completed more than £400mn lifetime mortgage sales.  
 
In 2015, L&G directly entered both the US and European pension risk transfer 
markets. It executed a $450m transaction with the US subsidiary of Royal Philips 
covering 7,000 scheme members in October and a €200m deal with ASR Nederland 
NV, a Dutch insurer in December. The pension obligations were transferred to L&G 
Re in cooperation with Hannover Re. L&G said: ‘The pension risk transfer market has 
become a global business…The potential market for pension risk transfer in the US, 
UK and Europe is huge, and will play out over many decades’. Two US insurers were 
also involved in the Royal Philips deal: Prudential Financial also acquired $450m of 
scheme liabilities covering another 7,000 members, while American United Life 
Insurance Company issued annuity contracts to 3,000 deferred scheme members, 
valued at $200m. 
 
In January 2015, the Bell Canada Pension Plan executed a C$5bn longevity swap with 
Sun Life Financial,33 SCOR, and RGA Re; it was SCOR’s first transaction in North 
America. In the process, Canada became the first country apart from the UK to have 
all three pension risk transfer solutions actively in use.  In June 2015, Delta Lloyd 
did a second €12 billion longevity swap with RGA Re. In July 2015, Aegon did one 
valued at €6 billion with Canada Life Re, a new entrant to the de-risking market in 
2015. Another new entrant was Scottish Widows. 
 
In June 2015, the Mercer Pension Risk Exchange was launched. It gives clients in the 
US, UK and Canada up to date buy-in and buy-out pricing based on their scheme’s 
data. It collects prices provided monthly by insurers in the bulk market, based on 
scheme benefit structures and member data. Mercer said: ‘Many companies have the 
appetite to transfer pension risk off their balance sheet but they face barriers: lack of 
clear information about the true cost of a buy-in or buy-out, limited transparency, the 
fluctuation of market rates and scheme economics to name but a few. [The exchange 
will enable] sponsoring employers and trustees to be more strategic and sophisticated 
in their approach and to know that they are executing a buy-in or a buy-out at the best 
time for them and at a competitive price’. 
                                                 
32 The Pension Regulator and the Pension Protection Fund, Purple Book 2015. 
33 Sun Life Financial also uses the RMS Longevity Risk Model. 
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In April 2016, WTW released PulseModel which uses medical science and the 
opinions of medical experts to improve longevity predictions. For example, the model 
predicts that 16% of 50-year-old men in the UK will develop type-2 diabetes in the 
next 20 years, but this rises to 50% for those who are both obese and heavy smokers. 
Overall, the model predicts that longevity improvements in the future will be lower 
than currently predicted, at around 1% p.a. rather than 1.5%. If this turned out to be 
correct, then the current price of longevity of risk transfer products would be too high. 
In 2016, there were a total of £8.6bn in buy-outs and buy-ins and £1.6bn in longevity 
swaps.34  
The largest buy-in in 2016 (in December) was Phoenix Life’s £1.2bn buy-in for the 
4,400 pensioners in the PGL Pension Scheme, which is sponsored by the Phoenix 
Group, Phoenix Life’s parent company. This replaced a longevity swap it had set up for 
the plan in 2014. This is the first example a transaction which transforms a longevity 
swap into a bulk annuity. Phoenix Life saw this as an opportunity to bring £1.2bn of 
liquid assets (mostly UK government bonds) onto its balance sheet, which could then 
be swapped into a higher yielding, matching portfolio, structured to maximize the 
capital benefit under Solvency II.35 This, in turn, meant that Phoenix Life would be 
assuming the market risks associated with the PGL Scheme pension liabilities in 
addition to the longevity risks. This made sense, given it already does this on its 
existing book of individual annuities which are backed by £12bn of assets.  The timing 
was critical too. Phoenix wanted to ensure that its internal model under Solvency II had 
bedded down well and that the capital and balance sheet impacts of the transaction were 
well understood, and that Phoenix had elicited the full support of its regulator (the 
Prudential Regulation Authority) for the transaction, thereby ensuring execution 
certainty. Phoenix also provided comfort to the plan’s trustees by giving them ‘all-risks' 
cover from point of buy-in (‘all-risks' cover is not usually provided until buy-out) and 
strong collateral protection.36 
In 2016, the UK office for National Statistics reported that longevity improvements 
rates have slowed down since 2011, especially at high ages; but it is not yet clear 
whether this is a genuine change in trend or the result of overestimating the number of 
older people at the time of the 2001 census, which had the effect of artificially reducing 
the high-age mortality rate between 2001 and 2011.37 Nevertheless, it prompted a 
debate in the UK in 2016 about the reliability of life expectancy projections. Mortality 
improvements in UK males averaged 1% over the preceding three years, compared 
with 3% in the decade before. Tim Gordon, head of longevity at Aon Hewitt said: ‘This 
is the most extreme reversal in mortality improvement trends seen in the past 40 years. 
What was initially assumed by many actuaries to be a blip is increasingly looking more 
like an earlier-than-expected fall-off in mortality improvements. The industry is 
currently trying to digest all the implications of this emerging information and – 
inevitably – it is taking time to feed through into insurance and reinsurance pricing’. 
Others say that this could just be ‘noise’. Matt Wilmington, director of pension risk 
transfer at L&G, points out that: ‘Two years doesn’t make a trend – it’s very volatile 
                                                 
34 Pensionfundsonline, 15 December 2016. 
35 Solvency II came into effect at the beginning of 2016. 
36 Stephanie Baxter (2017) How PGL's longevity swap was converted into a buy-in, Professional 
Pensions, 10 April. 
37 Anthony Hilton (2016) Life line, Pensions World, May. See also Cairns et al. (2016). 
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from year to year. If we had another five years where we saw far fewer deaths than 
expected, then we might start to see fairly significant changes, but where we are now, 
there’s not enough to persuade us – or many of the pension plans we work with – that 
there’s a vast reversal in trend in terms of life expectancy just yet’. Tim Gordon also 
warns against attempts to time the market: ‘Timing the longevity market in the same 
way you would time an equity market is extremely difficult, and plans could be in 
danger of missing opportunities now if they did that’.38 Nevertheless, the difference in 
mortality improvement rates is equivalent to a difference in liabilities of 1% or four 
months of pension payments for every retiree: UK pension liabilities would be £25bn 
lower if the future mortality improvement rate were 1% rather than 3%.39 Consultant 
Barnett Waddingham has put forward the suggestion that higher health and social care 
spending between 2000 and 2010 may have caused a blip in longevity estimates by 
accelerating improvements. Since 2009, health spending has been flat in real terms and 
there have been lower mortality improvements.40 
2016 saw the beginning of a trend towards consolidation amongst insurance companies 
involved in the longevity risk transfer business in the UK. For example, Aegon sold its 
£9bn UK annuity portfolio to Rothesay Life and L&G in April and May, as part of a 
strategy to free up capital from non-core business. Part of the reason for this is the 
additional capital requirements under Solvency II which only the most efficient firms 
have the ability to absorb. Similarly, in September, Deutsche Bank sold its Abbey Life 
subsidiary to Phoenix Life, a consolidator of closed insurance books, for £935mn, as 
part of a planned programme of disposals aimed at restoring its capital base. There is an 
estimated £100bn of UK individual annuities in back books and further consolidation 
of these back books is anticipated. One striking example of this is the UK Prudential 
which is rumoured to be selling its £45bn UK annuity and pension liability businesses 
due to an inadequate return on capital and transferring that capital to its growing 
businesses in Asia. Reinsurance deals also increased in response to Solvency II. For 
example, Pension Insurance Corporation executed a £1.6 billion longevity reinsurance 
agreement with the Prudential Insurance Company of America in June 2016. Solvency 
II has also been blamed for some companies pulling out of the bulk annuities market 
altogether, a key example being the UK Prudential in January 2016.  
2016 also witnessed the increasing streamlining and standardization of contracts. This 
is particularly beneficial to small schemes below £100m. Previously, smaller schemes 
have been less attractive to insurers on account of the higher costs to the insurer of the 
pricing the transfer relative to profit. To circumvent this, consultants have begun 
offering services that allow smaller schemes to access improved pricing and better 
commercial terms using a standardised off-the-shelf process incorporating 
pre-negotiated legal contracts. Pricing is more competitive because the insurer’s costs 
are kept low. An example is WTW’s Streamlined Bulk Annuity Service. The 
increasing maturity of the market has meant that some larger schemes have also been 
prepared to use pre-negotiated contracts.41 
                                                 
38 Quoted in Jenna Gadhavi (2017) Does the bell toll for longevity swaps?, Engaged Investor, 13 
January. 
39 Professional Pensions, 26 January 2017. 
40 Professional Pensions, 29 March 2017. 
41 Willis Towers Watson (2017) Key themes in the longevity hedging and bulk annuity market: 
De-risking report 2017. 
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Finally, 2016 was the tenth anniversary of the longevity transfer market. Since its 
beginning in the UK in 2006, £40bn of buy-outs and £31bn of buy-ins have taken place 
in the UK, covering 1mn people. Yet this equates to just 5% of the £1.5trn of UK 
defined benefit (DB) pension assets and 3% of the £2.4trn of DB liabilities on a buy-out 
basis. In addition, there have been £60bn of longevity swaps.42 Figure 1 shows the 
growth of the global market in longevity risk transfer between 2007 and 2016. A total 
of $280bn in transactions have been completed during this period. 
                                                 
42 LCP, Professional Pensions (15 December 2016 and 26 January 2017). Since 2007, some 92 buy-ins 
have been completed, worth a total of £30.6bn – see Table 1. 
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Figure 1:  Cumulative Pension Risk Transfers by Product and Country, 2007-16 
 
 
Sources: LCP, Hymans Robertson, Prudential Financial, Daniel Ben-Ami (2016) Preparing for a jump in longevity, Pensions & Investments Europe, December. 
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In order to reduce the costs of de-risking, pension schemes are encouraged to perform some 
liability reduction exercises, the key ones being:43 
 Enhanced transfer values (ETVs) – allow deferred members to transfer an uplifted 
value of their benefits to an alternative arrangement 
 Flexible retirement options (FROs) – allow deferred members aged 55 and over to 
retire early, or to take a transfer value and secure benefits in a different format 
from their scheme benefits, or to use funds for drawdown purposes 
 Pension increase exchanges (PIEs) – allow pensioners to exchange non-statutory 
increases for a higher immediate pension with lower or even zero future increases 
(e.g., a £10,000 annual pension with RPI uplifting is replaced by a £12,000 annual 
pension with no further increases) 
 Trivial commutations (TCs) – allow members with low value benefits to cash 
these in. 
The most common exercises currently in the UK are PIEs and TCs – and these can be 
conducted either before or at the same time as a bulk purchase annuity broking exercise.   
 
Innovation is a continuing feature of this market. Some examples include:44 
 Buy-ins and buy-outs with deferred premium payments – to spread costs 
 Phased de-risking using a sequence of partial buy-ins with an ‘umbrella’ structure 
to avoid more than one set of contract negotiations – to spread costs 
 Accelerated buy-ins – the insurer provides a loan to the scheme equal to the deficit 
(sometimes called a winding up lump sum (WULS)), so that a partial buy-in can 
take place immediately, with this converting to a full buy-in when the loan has been 
repaid, with the option of a full buy-out at a later date 
 Forward start buy-ins – a standard buy-in with the start date delayed to reflect the 
level of funding available, with additional options, such as paying deferred 
members as and when they retire if this is prior to the start date, or the ability to 
bring forward the start date for an additional fee 
 Top-slice buy-ins – to target the highest value liabilities 
 Named-life longevity swap – if the named member lives longer than expected, the 
insurer pays out the difference (examples being the £400m Bentley scheme or an 
unnamed scheme with 90 named pensioners valued at £50m) 
 Longevity swaps for small pension schemes with liabilities of £50-100m – 
previously only available for medium (£100-500m) and large schemes (above 
£500m). 
 Longevity swap to buy-in conversions – as pioneered by Phoenix Life in December 
2016. Solvency II incentivises buy-in providers to hold longevity insurance, 
otherwise they pay an additional risk margin.  This encourages buy-in providers to 
seek out schemes which already have a longevity hedge and encourage them to do a 
buy-in. Another driver is longevity swap providers that have withdrawn from this 
market – such as Deutsche Bank and Credit Suisse – but are still responsible for 
running off their existing swaps. They might have an incentive to encourage the 
                                                 
43 Professional Pensions (2016) Risk Reduction and the Extent of Trust in Pension Scheme Advisors and 
Providers, June, p.26. 
44 Legal & General and Engaged Investor (2016) De-risking Journeys of Mid-sized Pension Schemes, June. 
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associated pension plan to novate the swap to a buy-in provider and hence 
extinguish their liability.45 
 Increasing optionality in contracts to improve flexibility – for example, the option 
to switch the indexation measure for pensions in payment from the Retail Price 
Index to the Consumer Price Index if government legislation changes; or the option 
to secure discretionary benefits, such as actual inflation above a 5% cap; or 
surrender options; or the option for a contract to be novated to another insurer if a 
scheme wants to buy-in or buy-out benefits with another insurer in the future. 
 Combining liability management solutions (such as interest rate and inflation 
swaps) and bulk annuities in a buy-out – so instead of completing liability 
management before considering a buy-out, schemes do this in a single exercise 
 ‘Buy-out aware’ investment portfolios – used to reduce buy-out price volatility and 
close the funding shortfall, with the buy-out price locked to the value of the buy-out 
aware funds once a target shortfall has been reached and whilst the contract 
documentation for a buy-out is being completed. 
 
These are all innovations in the space linking pension schemes and insurance companies 
designed to ease the transfer of pension liabilities (or at least the longevity risk in them) 
from pension schemes to insurance companies. But there is now an increasing sign of 
capacity constraints within insurance companies. As one consultant said: ‘Given the 
market has historically completed only 150-200 deals in any one year, there is a real risk 
of capacity constraints in the market, not just from an insurer capital perspective, but also 
from a resource and expertise perspective’.46  
 
In April 2017, the International Monetary Fund (IMF) released a new edition of its Global 
Financial Stability Report. Chapter 2 (‘Low Growth, Low Interest Rates, And Financial 
Intermediation’) suggests that DB pension funds across the globe might have to cut 
benefits ‘significantly’ in the long term because of ultra-low interest rates. Attempts to 
increase returns by changing asset allocations ‘appears feasible only by taking potentially 
unacceptable levels of risk’. In the face of such low rates, the IMF argues that ‘life insurers 
and pension funds would face a long-lasting transitional challenge to profitability and 
solvency, which is likely to require additional capital’ or would require a ‘very high’ level 
of volatility risk to meet their funding goals. However, a combination of risk aversion and 
regulatory constraints was likely to deter the vast majority from taking this second path. 
The IMF instead believes that the current situation might work to the benefit of insurers 
backing buy-ins and buyouts. With investors increasingly monitoring the size of DB 
liabilities and the effects on company share prices, profits, and dividends, the IMF said 
offloading these liabilities to insurers ‘is an attractive option’ and ‘may represent a 
market-efficient arrangement’ and that ‘regulation could play an important role in this area 
by facilitating such transactions’. 
 
 
                                                 
45 Stephanie Baxter (2017) Converting longevity swaps into bulk annuities: The next de-risking innovation?, 
Professional Pensions, 13 April. 
46 Martyn Phillips, Mercer (quoted in Professional Pensions (2016) Risk Reduction and the Extent of Trust 
in Pension Scheme Advisors and Providers, June, p.28). 
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The only long-term solution to this capacity constraint is to bring in new investors from the 
capital markets (i.e., to transfer the risk to the capital markets). These investors will include 
sovereign wealth funds, ILS hedge funds and private equity investors. But these investors 
need some assurance that they are not going to be sold a ‘lemon’. There have been many 
attempts over the last decade to provide this assurance – without any real success. One 
potential solution to this problem was discussed in a plenary session at the L12 conference, 
namely insurance sidecars – which are a way to share risks with new investors when the 
latter are concerned about the ceding insurer having an informational advantage – see 
Figure 2.47 
 
Figure 2: Sidecar investing 
 
 
 
Source: Prudential Retirement 
 
 
At the same time as these practical developments in the capital markets were taking place, 
academics were continuing to make progress on theoretical developments, building on the 
original idea of using longevity bonds to hedge longevity risk in the capital markets (Blake 
and Burrows, 2001). These included: 
 Design and pricing of longevity bonds and other longevity-linked products (e.g., 
Blake et al. (2006a,b), Bauer (2006), Bauer and Ruβ (2006), Antolin and 
Bloomestein (2007), Bauer and Kramer (2007), Denuit et al. (2007), Barbarin 
(2008), Bauer et al. (2010b), Chen and Cummins (2010), Kogure and Kurachi 
(2010), Bravo (2011), Dowd et al. (2011a), Mayhew and Smith (2011), Zhou et al. 
(2011, 2013), Chen et al. (2013), Shen and and Siu (2013), Blake et al. (2014), 
Denuit et al. (2015), Hunt and Blake (2015), Milevsky and Salisbury (2015), Yang 
et al. (2015), Chen et al. (2017), Lin et al. (2017b)). 
 Design and pricing of longevity-linked derivatives (e.g., Shang et al. (2011), Lin et 
al. (2013), Wang and Yang (2013), Chuang and Brockett (2014)) and specifically 
survivor/longevity swaps (e.g., Dowd et al. (2006), Wang et al. (2013, 2015)), 
survivor/longevity forwards and swaptions (e.g., Dawson et al. (2010)), q-forwards 
(e.g., Deng et. al. (2012), Barrieu and Veraart (2016)), mortality options (e.g., 
Milevsky and Promislow (2001)), and guaranteed annuity options (e.g., Gao et al. 
(2015)) 
                                                 
47 Kessler et al. (2016) 
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 Pricing longevity risk (e.g., Olivieri and Pitacco (2008), Bayraktar et al. (2009), 
Chen et al. (2010), Li (2010)). 
 The pricing of longevity-related guarantees (e.g., Yang et al.(2008)) 
 The pricing and hedging of life settlements (e.g., Deng et al. (2011), Brockett et al. 
(2013), Zhu and Bauer (2013), MacMinn and Zhu (2017)) 
 Longevity and mortality indices (e.g., Denuit (2009), Li et al. (2011), Chan et al. 
(2014), Tan et al. (2014)) 
 Securitization of longevity risk (e.g., Dahl (2004), Chen and Cox (2009), Cowley 
and Cummins (2005), Lin and Cox (2005), Cairns et al. (2006a), Cox and Lin 
(2007), Biffis and Blake (2010), Wills and Sherris (2010), Lane (2011), Mazonas et 
al. (2011), Biffis and Blake (2013, 2014), Blake et al. (2013), Yang and Huang 
(2013), Michaelson and Mulholland (2014), MacMinn and Brockett (2017)) 
 Management and hedging of longevity risk (e.g., Dahl and Møller (2006), 
Friedberg and Webb (2007), Cocco and Gomes (2008), Tsai et al. (2010), Wang et 
al. (2010), Coughlan et al. (2011), Koijen et al. (2011), Li and Hardy (2011), and 
Tzeng et al. (2011), Wang et al. (2010, 2011b), Ngai and Sherris (2011), Barrieu et 
al. (2012), International Monetary Fund (2012), Li and Luo (2012), Cairns (2013), 
Cox et al. (2013a,b), Qiao and Sherris (2013), Cairns et al. (2014), Zelenko (2014), 
Zhu and Bauer (2014, Li et al. (2017), Zhou and Li (2017))) 
 Mortality modeling, mortality term structure 48  modelling, and mortality 
forecasting (e.g., Hobcraft et al. (1982), Booth et al. (2002a,b), Brouhns et al. 
(2002a,b, 2005), Renshaw and Haberman (2003a,b, 2006, 2008), Currie et al. 
(2004), Biffis (2005), Czado et al. (2005), Delwarde et al. (2007), Cairns et al. 
(2006b, 2008a,b, 2009, 2011a), Koissi et al (2006), Pedroza (2006), Bauer et al. 
(2008), Blake et al. (2008), Gourieroux and Monfort (2008), Hari et al. (2008), 
Kuang, et al. (2008a,b), Haberman and Renshaw (2009, 2011, 2012, 2013), 
Hatzopoulos and Haberman (2009, 2011), Li et al. (2009), Plat (2009a,b), Wang 
and Preston (2009), Bauer et al. (2010a), Biffis and Blake (2010), Biffis et al. 
(2010), Cox et al. (2010), Debonneuil (2010), Dowd et al. (2010a,b,c, 2016), Lin 
and Tzeng (2010), Murphy (2010), Yang et al. (2010), Coelho and Nunes (2011), 
D’Amato et al. (2011), Gaille and Sherris (2011), Li and Chan (2011), Milidonis et 
al. (2011), Russo et al. (2011), Russolillo et al. (2011), Sweeting (2011), Wang et 
al. (2011a), Yue and Huang (2011), Zhu and Bauer (2011), Alai and Sherris 
(2014b), Aleksic and Börger (2012), D’Amato et al. (2012a,b), Hainaut (2012), 
Hyndman et al. (2013), Kleinow and Cairns (2013), Mitchell et al. (2013), Nielsen 
and Nielsen (2014), Hunt and Blake (2014), Mayhew and Smith (2014), Villegas 
and Haberman (2014), Danesi at al. (2015), Hunt and Villegas (2015), Li et al. 
(2015), O’Hare and Li (2015), Tomas and Planchet (2015), Berkum et al. (2016), 
Currie (2016))49 
                                                 
48 The mortality term structure is the two-dimensional surface showing projected mortality rates at different 
ages for different future years. 
49 In December 2015, the UK Continuous Mortality Investigation (CMI), a subsidiary of the Institute and 
Faculty of Actuaries, reported that UK mortality improvements over the previous four years have been much 
lower (close to zero) than equivalent periods over the previous 40 years (the average rate between 2001 and 
2011 was 2.4% p.a.), raising the question of whether mortality improvements have at last begun to slow 
down. The 2016 release of the CMI’s mortality forecasting model – which is used by over 90% of UK 
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 Multi-population mortality modelling (e.g., Darkiewicz and Hoedemakers (2004), 
Li and Lee (2005), Cairns et al. (2011b), Dowd et al. (2011b), Jarner and Kryger 
(2011), Njenga and Sherris (2011), Börger and Ruß (2012), D’Amato et al. (2014), 
Zhou et al. (2014), Chen et al. (2015), Kleinow (2015), Li et al. (2015), Biffis et al.  
(2017), Milidonis and Efthymiou (2017), Zhu et al. (2017)) 
 Cause-of-death mortality modelling (e.g., Hanewald (2011), Alai et al. (2014), 
Gourieroux and Lu (2015)) 
 Longevity risk and financial innovation (improvements in the analysis and design 
of longevity-linked products) (e.g., Gong and Webb (2010), Stevens at al. (2010), 
Richter and Weber (2011), Cocco and Gomes (2012), Brown and Warshawsky 
(2013)) 
 Reverse mortgages (e.g., Wang et al. (2008), Huang et al. (2011), Yang (2011), 
Alai et al. (2014a), Kogure et al. (2014), Shao et al. (2015)) 
 Longevity risk in investment portfolios (e.g., Milevsky and Young (2007), 
Menoncin (2008), Horneff et al. (2008, 2009, 2010, 2015), Huang et al. (2012), 
Maurer et al. (2013), Ai et al. (2017)) 
 Longevity risk in pension plans and pension systems (e.g., Aro (2014), Bisetti and 
Favero (2014), Donnelly (2014), Lin et al. (2014, 2015, 2017a), Ai et al. (2015), 
Wan and Bertschi (2015), Lin et al. (2017a)). 
 
 
As mentioned before, not all paths to progress are smooth. In recent years, this has been 
particularly true currently in the largest market dealing with micro-longevity risk, namely 
life settlements. 50  The life settlements market has been dogged by systematic 
underestimates of policy holders’ life expectancies by certain medical underwriters, issues 
concerning premium financing, frauds, and ethical issues associated with ‘profiting’ from 
individuals dying and policies maturing. In December 2009, Goldman Sachs announced it 
was closing down its QxX.LS index. This was partly because of the reputational issues 
associated with life settlements, but mainly because of insufficient commercial activity in 
the index. While the ethical issues are no different in substance from those relating to the 
macro-longevity market (see, e.g., Blake and Harrison, 2008), the micro-longevity market 
needs to learn some important lessons from the macro-longevity market. The 
macro-longevity market has been very successful at promoting good basic research on the 
analysis of the stochastic mortality forecasting models it uses and putting these models into 
the public domain and has also been much more transparent with the data it uses. This 
suggests a way forward for the life settlements micro-longevity market.  
                                                                                                                                                 
pension funds to make their mortality projections – reports that there is increasing evidence that the low level 
of mortality improvements in the UK since 2011 may be due to medium- or long-term influences instead of 
being a short-term blip. The effect could be to reduce the aggregate deficit in UK pension schemes from 
£530bn to £220bn. 
50  The market for micro-longevity risk trades assets involving a small number of lives. In the case of life 
settlements, for example, the products involve individual lives and hence are subject to a significant degree of 
idiosyncratic mortality risk. This contrasts with the market for macro-longevity risk which deals with pension 
plans and annuity books and hence involves a large number of lives: here idiosyncratic mortality risk is much 
less important than systematic mortality risk which is essentially the trend risk of getting life expectancy 
projections wrong. 
 6 
 
 
 
Another setback, this time to the macro-longevity market, occurred in April 2012 when a 
number of investment banks – Credit Suisse, Nomura and UBS – pulled out of the 
longevity risk transfer market as a result of additional capital requirements under Basel III. 
Investment banks had already been disadvantaged in this market by the US Dodd-Frank 
(Restoring American Financial Stability) Act 2010 which prevented US banks and their 
affiliates from entering longevity swaps and synthetic trades in life settlements. At around 
the same time, however, a number of insurers and reinsurers entered the market, i.e., 
Prudential (US), SCOR and Munich Re. Despite these new entrants, the following year 
witnessed the start of a process of consolidation in the insurance industry. In August 2013, 
Lucida was purchased by L&G for £150m; at that time, it had 31,000 pensioners on its 
books and £1.4 billion in pension assets. In February 2014, the buy-out business of 
MetLife, which entered the market in 2007 and acquired the pension assets of 20,000 
pensioners worth £3 billion, was sold to Rothesay Life for an undisclosed sum, bringing its 
total assets to £10 billion.   
 
In December 2013, Goldman Sachs sold the majority of its stake in Rothesay Life to 
Blackstone (28.5%), Government of Singapore Investment Corporation (GIC) (28.5%), 
and MassMutual (7%), due to the new regulatory capital requirements faced by banks and 
insurers.  
The new Trump administration in the US has promised to repeal the 2010 Dodd-Frank Act 
and restore the 1933 Glass-Steagall Act. The former Act, introduced in the aftermath of the 
Global Financial Crisis and 2,300 pages long, has cost US banks up to $36bn in regulatory 
costs and forced them to end proprietary trading, a key factor explaining why US banks 
exited from the longevity risk transfer market, except for those banks, such as Goldman 
Sachs, which had insurance company subsidiaries. The latter Act, just 37 pages long, 
would require the separation of the investment banking and retail banking arms of the 
largest Wall St banks. These changes might lead to US banks looking again at the longevity 
risk transfer market. 
As with the previous conferences, Longevity 11 consisted of both academic papers and 
more practical and policy-oriented presentations. The conference was addressed by the 
following keynote speakers: 
 
 Denis Jacquat (Assemblée Nationale) who gave a presentation entitled ‘Longevity 
and Aging Issues in France: a Member of Parliament's Perspective’. 
 Jessica Mosher (OECD) who discussed the findings of the 2014 OECD study 
‘Mortality Assumptions and Longevity Risk – Implications for Pension Funds and 
Annuity Providers’. 51  One of the recommendations of the study was that 
‘Governments should encourage the development of a market for instruments to 
hedge longevity, particularly index-based instruments, by facilitating transparency 
and standardization of longevity hedges in order to ensure the capacity for 
                                                 
51 dx.doi.org/10.1787/9789264222748-en 
 7 
 
 
pension plans and annuity providers to continue to provide longevity protection to 
individuals’. 
 Ronald Lee (University of California at Berkeley) in a presentation entitled 
‘Widening Socioeconomic Differences in Mortality and the Progressivity of Public 
Pensions and other Programs for the Elderly’ discussed the results of the US 
National Academy of Sciences’ study ‘The Growing Gap in Life Expectancy by 
Income: Consequences and Policy Responses’. The study found that the top half of 
the income distribution has benefited much more from rising life expectancy than 
the bottom half, while widening mortality differentials have reduced the 
progressivity of public transfers substantially. Professor Lee argued that these 
points should be considered when designing policy responses to population aging. 
 Tom Kirkwood (Newcastle University) gave a presentation called ‘Why and How 
are We Living Longer?’. He began by pointing out that, contrary to widely held 
belief, the body is not programmed to age and die. Rather, the body is 
programmed for survival. However, there was no evolutionary pressure to invest 
in a body that might live forever. Ageing is caused by the accumulation of 
damage, particularly to the body’s cells. Professor Kirkwood said we needed to 
address the following key questions: (a) Can we identify the precise factors 
contributing to the malleability of longevity and health in old age?, (b) Can we 
improve our understanding of age-related multi-morbidity?, (c) Can we use such 
knowledge further to promote health in old age and to reduce frailty and 
dependency?, and (d) What mechanisms do we need to set in place to track trends 
in incidence of age-related diseases? 
 Laurent Schwartz (Ecole Polytechnique) talked on the subject of ‘Cancer 
Mortality: Towards a Structural Change?’. Cancer treatments have so far been less 
successful than the treatments for other diseases. Dr Schwartz said the solution was 
to identify the combination of drugs that would be active against altered cancer cell 
metabolism. For example, one study showed long-term stabilization with IV 
Lipoicacid and low dose naltrexone. The current state of knowledge is that (a) 
cancer is most probably the simple consequence of mitochondrial inactivation and 
(b) Alzheimer’s disease has a lot of common features with cancer. 
 Andre De Vries (RGA) gave a presentation entitled ‘Capital Motivated Longevity 
Transactions in Practice’. He introduced a product called the ‘Longevity Shock 
Absorber’ (LSA) which is designed to strike a balance between the costs and 
benefits to insurers using it. The LSA transfers remote (i.e., tail, but not extreme) 
longevity risk and thereby improves the insurer’s capital position under Solvency 
II. It improves both sides of the Solvency Ratio, by increasing Own Funds and 
decreasing the Solvency Capital Requirement. The LSA has an attractive price 
relative to other capital management solutions. 
 Guy Coughlan (Universities Superannuation Scheme) gave a talk called 
‘Longevity – it’s academic’ which analyzed the mortality and longevity 
characteristics of the members of the largest funded UK pension plan. The 
membership of the plan is large, geographically diverse, and yet reasonably 
homogeneous in terms of demographic profile. As such it provides a unique case 
study and interesting comparisons with other populations. 
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 Avery Michaelson (Société Générale Corporate and Investment Banking) talked 
about ‘Indexed vs. Indemnity Longevity Hedges’, based on the analysis in 
Michaelson and Mulholland (2014). 
 Jean-Marie Robine (INSERM) provided an ‘Update on the Adult Longevity 
Revolution’. The main findings are: (a) a dramatic increase in the number of 
centenarians, (b) both a compression and shifting of mortality, and c) an apparent 
limit to the maximum life span between 110 and 115. 
 Mark Flint (SCOR) gave a presentation on ‘The Impact of Recent Regulatory 
Change on the UK Individual Annuity Market’. The overwhelming tax incentive to 
use personal pension savings to buy an annuity was (effectively) removed from 
April 2015. Annuities are viewed as bad value by the media in the UK. The 
annuity market has fallen by around 60%, after peaking at over £12bn in 2012, 
but now appears to be stabilizing at the new lower level. A large proportion of 
annuities are still purchased without shopping around. Although there is 
significant uncertainty, initial signs are that annuities will continue to play a 
significant role under the new Pension Freedoms. Annuities and other products 
that enable insurance of longevity risk are likely to be rated by postcode and 
medical status in future (i.e. medically underwritten). 
 Philip Simpson (Milliman) reported on ‘Recent Developments in the UK 
Longevity Market’: (a) a continuous relatively constant decline in male and female 
mortality rates, (b) some suggestion in recent years that the decline might be 
slowing down, and (c) a decline in deaths from circulatory diseases is the most 
significant disease-based contributor to improvement. Mr Simpson described the 
current state of the UK longevity market: (a) low bond yields and equity market 
volatility has made pension scheme buyouts seem expensive, (b) Solvency II is 
likely to make deals with insurers more expensive in the future, since insurers 
expect capital requirements under Solvency II (which came into effect at the 
beginning of 2016) to be higher than under the previous system, especially for 
new business, (c) insurers seeking to reinsure significant volumes of longevity 
risk both via longevity swaps and asset-based deals, (d) capital market 
transactions, as opposed to reinsurance, remain few and far between, and many 
banks have effectively withdrawn from the longevity market, and (e) most deals 
are on an indemnity basis with few index based transactions. 
 Amy Kessler (Prudential Retirement) talked about the ‘The Longevity Risk 
Transfer Market at $250bn – Innovation, Golobalization and Growth’. She pointed 
out that in the US, UK, Canada and the Netherlands $250bn in pension liabilities 
have been transferred to insurers and reinsurers since 2007. All kinds of 
companies were benefiting from flexible risk transfer solutions that secured 
member benefits and helped corporate sponsors achieve a lower risk future. 
Innovation has been crucial to recent growth as insurers and reinsurers have 
broken through the early barriers to large transactions by perfecting a full range of 
solutions for pension funds of all shapes and sizes. Globalization was just 
beginning with activity spreading to France, Germany, Switzerland, the Nordics, 
and Australia in the coming years. 
 Finally, there were two round tables: 
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o ‘Big Data and Longevity’  with Frederic Planchet (SAF Laboratory), 
Alexander Zhavoronkov (John Hopkins University) and Pierre-Henri 
Tavoillot (Paris Philosophy College) 
o ‘Longevity and Long Term Care’ with Jean-Herve Lorenzi (Edmond de 
Rothschild), Serge Guerin (ESG) and Jean-Micheal Ricard (Siel Blue). 
The academic papers that were selected by us as the editors of this Special Issue went 
through a refereeing process subject to the usual high standards of Insurance: Mathematics 
and Economics. They cover the following themes: mortality bonds, risk in pension plans 
and retirement income, the valuation of annuities and reverse mortgages, longevity risk 
hedging and sharing, cause of death mortality, and mortality modelling. We briefly discuss 
each of the 16 papers selected.   
 
In ‘The Choice of Trigger in an Insurance Linked Security: The Mortality Risk Case’, 
Richard MacMinn and Andreas Richter begin by pointing out that in 2003, Swiss Re 
introduced a mortality-based security designed to hedge excessive mortality changes for 
its life book of business. The concern was mortality risk, i.e., the risk of premature death. 
The mortality risk due to a pandemic is similar to the property risk associated with 
catastrophic events such as earthquakes and hurricanes and the security used to hedge the 
risk is similar to a CAT bond. The authors look at the incentives associated with 
insurance-linked securities. They consider the trade-offs an insurer or reinsurer faces in 
selecting a hedging strategy and compare index and indemnity-based hedging as 
alternative design choices and ask which is capable of creating the greater value for 
stakeholders. Additionally, they model an insurer or reinsurer that is subject to insolvency 
risk, which creates an incentive problem, known as the judgment proof problem. The 
corporate manager is assumed to act in the interests of shareholders and so the judgment 
proof problem yields a conflict of interest between shareholders and other stakeholders. 
Given the fact that hedging may improve the situation, the analysis addresses what type 
of hedging tool would be best. The authors show that an indemnity-based security tends 
to worsen the situation, as it introduces an additional incentive problem. Index-based 
hedging, on the other hand, under certain conditions turns out to be beneficial and 
therefore dominates indemnity-based strategies. This result is further supported by 
showing that for the same sufficiently small strike price the current shareholder value is 
greater with the index-based security than the indemnity-based security. 
 
In ‘Pension Risk Management with Funding and Buyout Options’, Samuel H. Cox, Yijia 
Lin and Tianxiang Shi show that there has been a surge of interest in recent years from 
defined benefit pension plan sponsors in de-risking their plans with strategies such as 
‘longevity hedges’ and ‘pension buyouts’. While buyouts are attractive in terms of value 
creation, they are capital intensive and expensive, particularly for firms with underfunded 
plans. The existing literature mainly focuses on the costs and benefits of pension buyouts. 
Little attention has been paid to how to capture the benefits of de-risking within a plan’s 
financial means, especially when buyout deficits are significant. To fill this gap, the 
authors propose two options, namely a pension funding option and a pension buyout 
option, that provide financing for both underfunded and well-funded plans to cover the 
buyout risk premium and the pension funding deficit, if a certain threshold is reached. 
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To increase market liquidity, the authors create a transparent pension funding index, 
calculated from observed capital market indices and publicly available mortality tables as 
well as pension mandatory contributions, to determine option payoffs. A simulation 
based pricing framework is then introduced to determine the prices of the proposed 
pension options. Numerical examples show that these options are effective and 
economically affordable. Moreover, sensitivity analyses demonstrate the reliability of the 
pricing models. 
 
In ‘The Effect of Longevity Drift and Investment Volatility on Income Sufficiency in 
Retirement’, Les Mayhew, David Smith and Douglas Wright recall that, in 2014, the UK 
Government announced radical proposals which will allow people to withdraw money 
from their pension pot from age 55, ‘how they want, subject to their marginal rate of 
income tax in that year’. The main effect of this change was to put more onus on the 
individual to make sure they have sufficient resources to last for their retirement, but it also 
removes the obligation to annutise their funds at any future age. This paper is concerned 
with how people can best use their pension pots by aligning them to their personal financial 
objectives and longevity risks. It finds that for most people annutising is not the best option 
except a few circumstances and that draw down is preferable, especially where there is a 
bequest and the individual has assets such as property to fall back on. These options are 
low risk if simple rules are followed but they are not a substitute for professional advice 
and should only be used in conjunction. 
 
In ‘Valuation of Longevity-linked Life Annuities’, Jorge Miguel Bravo and Najat El 
Mekkaoui de Freitas show that the fair value of a pure longevity-linked life annuity can 
be decomposed into a traditional fixed annuity and a basket of European-style longevity 
(call and put) options of different maturities with an underlying asset equal to a 
longevity-index and strike equal to the minimum (initial) guaranteed amount. The 
embedded longevity put (call) options give the annuity provider (annuitant) the right to 
periodically adjust the benefit payments downwards (upwards) if the observed 
survivorship rates are higher (lower) than those predicted at the contract initiation, 
transferring part of the longevity risk to the annuitant. Alternative decompositions for the 
payout stream of a capped longevity-linked life annuity are also explored. The authors 
incorporate capital market risk and assess how individuals with different risk aversion 
and subjective time preferences value the stochastic payout stream of both index-linked 
and participating contract structures. They discuss the valuation of the embedded 
longevity options using a risk-neutral simulation approach. The paper revisits and 
expands previous results on the problem of designing and pricing life annuity contracts 
which aim at sharing longevity and investment risk between annuity provider and 
annuitants within the context of building post-retirement income. 
 
In ‘Unisex Pricing of German Participating Life Annuities – Boon or Bane for Customer 
and Insurance Company?’, Sandy Bruszas, Barbara Kaschützke, Raimond Maurer and 
Ivonne Siegelin explore how the European Union requirement for gender-neutral 
premiums and the new rules for surplus participation in participating life annuities 
(PLAs) affect an insurance company’s profitability and policyholder’s wellbeing. The 
authors analyse real data observed for annuity prices in the German market followed by 
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an examination of the impact of the unisex calculation, allowing for different assumed 
and realised gender compositions. They develop a realistically calibrated asset and 
liability model for a PLA with stochastic mortality, interest rates, and equity returns. 
They show that for males, the disadvantages of a PLA’s unisex pricing as compared to a 
gender-specific calculation are substantially lower if measured using a lifetime utility 
framework that accounts for both distributed surpluses and stochastic mortality. For the 
insurance company, the gender mix composition turns out to be less important than the 
capital market effect. Moreover, PLAs turn out to be an efficient means to share actual 
mortality experience between insurance company and the annuitant, and can be, at least 
to a certain extent, considered a substitute for indemnity longevity hedge.	
 
In ‘Valuation of Variable Long-term Care Annuities with Guaranteed Lifetime Withdrawal 
Benefits: A Variance Reduction Approach’, Ming-hua Hsieh, Jennifer L. Wang, Yu-Fen 
Chiu, and Yen-Chih Chen propose a new product, the Variable Life Care Annuity with 
Guaranteed Lifetime Withdrawal Benefits (LCA-GLWB), and design an efficient 
valuation algorithm. This innovative product provides a comprehensive retirement 
solution for both longevity risk and long-term care protection. It includes the benefits of 
guaranteed income streams with downside risk protection and long-term care expenses for 
retirees. However, the valuation of this type of product is both complex and 
time-consuming. In this paper, the authors propose a Monte Carlo valuation algorithm that 
uses the variance reduction technique. The numerical results indicate that the proposed 
valuation algorithm is very efficient under a broad range of asset return models. The 
proposed algorithm provides a general approach for the rapid valuation of similar products 
and can help provide life insurance companies offering innovative products with an 
appropriate valuation tool.  
 
In ‘Profitability and Risk Profile of Reverse Mortgages: A Cross-System and Cross-Plan 
Comparison’, Yung-Tsung Lee, Ko-Lun Kung and I-Chien Liu conduct a cross-system 
and cross-plan comparison of reverse mortgages. They compare the systematic 
distinctions and analyze the risk and profitability of reverse mortgages in two prominent 
types of market arrangements: (a) a market where a public external insurer exists (i.e., the 
Home Equity Conversion Mortgage program in the U.S. market); and (b) a market where 
an external insurer is absent (i.e., the Australian market). Two typical payment plans, the 
lump-sum and annuity payments, are examined and compared using stochastic 
dominance criteria. The paper provides a complete framework for analysing the 
profitability and risk profile of reverse mortgage products. It argues that modern solvency 
capital requirements, such as Solvency II, may depress the loan-to-value ratio and the 
intervention of government may be necessary. The authors also demonstrate that the 
lender prefers lump-sum products and this may explain why such products dominate the 
market in practice. The study can help financial institutions and governments understand 
the properties of reverse mortgages and hence help to develop a reverse mortgage market. 
 
In ‘A Strategy for Hedging Risks Associated with Period and Cohort Effects Using 
q-Forwards’, Yanxin Liu and Johnny Siu-Hang Li argue that the stochastic nature of 
future mortality arises from both period (time-related) and cohort (year-of-birth-related) 
effects. Existing index-based longevity hedging strategies mitigate the risk associated 
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with period effects, but often overlook cohort effects. The negligence of cohort effects 
may lead to sub-optimal hedge effectiveness, if the liability being hedged is a deferred 
pension or annuity which involves cohorts that are not covered by the data sample. In this 
paper, the authors propose a new hedging strategy that incorporates both period and 
cohort effects. The resulting longevity hedge is a value hedge, reducing the uncertainty 
surrounding the τ-year ahead value of the liability being hedged. The proposed method 
is illustrated with data from the male population of England and Wales. It is found that 
the benefit of incorporating cohort effects into a longevity hedging strategy depends 
heavily on the persistence of cohort effects and the choice of q-forwards. 
 
In ‘Replicating Intergenerational Longevity Risk Sharing in Collective Defined 
Contribution Pension Plans using Financial Markets’, Enareta Kurtbegu argues that 
intergenerational risk sharing is often seen as a strong point of the Dutch pension system. 
The ability to absorb financial and actuarial shocks through the funding ratio allows for 
the smoothing of returns over generations. Nevertheless, it implicitly means that 
generations subsidize each other, which has its disadvantages, especially in the light of 
incomplete contracts and situations of hard regulation constraints. The paper highlights 
the advantages of intergenerational risk sharing as a main characteristic in certain 
collective pension plans, investigating if and how much of this can be replicated by 
individual participation in the market. Using a stylized model based on different pension 
plans such as ‘hard’/‘soft’ defined benefit, collective/ ‘pure’ defined contribution, the 
author identifies the effects of an increase in life expectancy as one of the most important 
demographic shocks. The existence of regulatory constraints modifies agents' behavior so 
that they tend to choose individual investment to ensure their retirement savings. In the 
absence of regulatory constraints, individual investment under-performs pension fund 
performance. Thus, choosing collective participation is more rational.  
 
In ‘Cause of Death Mortality: What Can be Learned from Population Dynamics’, Séverine 
Arnold, Alexandre Boumezoued, Héloïse Labit Hardy and Nicole El Karoui analyse 
cause-of-death mortality changes and its impacts on whole population evolution. The 
study combines cause-of-death analysis and population dynamics techniques. The aim is 
to measure the impact of cause-of-death reduction on the whole population age structure, 
and more specifically on the dependency ratio which is a crucial quantity for 
pay-as-you-go pension systems. Whereas previous studies on causes of death focused on 
mortality indicators, such as survival curves or life expectancy, the approach here 
provides additional information by including birth patterns. As an important conclusion, 
numerical results based on French data show that populations with identical life 
expectancies can present important differences in their age pyramid resulting from 
different cause-specific mortality reductions. Sensitivities to fertility level and population 
flows are also given. 
 
In ‘Using the Taiwan National Health Insurance Database to Model Cancer Incidence and 
Mortality Rates’, Jack C. Yue, Hsin-Chung Wang, Yin-Yee Leong and Wei-Ping Su 
show that increasing cancer incidence and mortality rates in Taiwan have worsened the 
loss ratio of cancer insurance products and created a financial crisis for insurers. The 
authors used data from the Taiwan National Health Insurance Research Database to 
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evaluate the challenge of designing cancer insurance products. They found the Lee-Carter 
and APC models have the smallest estimation errors, and the CBD and Gompertz models 
are good alternatives to explore the trend of cancer incidence and mortality rates, 
especially for the elderly people. The loss ratio of Taiwan’s cancer insurance products is 
expected to grow and this can be deemed as a form of longevity risk.  
 
In ‘Do Actuaries Believe in Longevity Deceleration?’, Edouard Debonneuil, Frédéric 
Planchet and Stéphane Loisel ask the question: As more and more people believe that 
significant life extensions may come soon, should commonly used future mortality 
assumptions be considered prudent? They find that commonly used actuarial tables for 
annuitants – as well as the Lee-Carter model – do not extrapolate life expectancy at the 
same rate for future years as for past years; instead they produce some longevity 
deceleration. This is typically because their mortality improvements decrease after a 
certain age, and those age-specific improvements are constant over time. As potential 
alternatives: (a) they study the Bongaarts model that produces straight increases in life 
expectancy; (b) they adapt it to produce best-practice longevity trends, (c) they compare 
with various longevity scenarios, including a model for ‘life extension velocity’, and (d) 
after gathering advances in bio-gerontology, they discuss issues to help retirement 
systems cope with a potential strong increase in life expectancy.  
 
In ‘The Double-gap Life Expectancy Forecasting Model’, Marius Pascariu, Vladimir 
Canudas-Romo and James W. Vaupel show that life expectancy is highly correlated over 
time among countries and between males and females. These associations can be used to 
improve forecasts. The authors propose a method for forecasting female life expectancy 
based on analysis of the gap between female life expectancy in a country compared with 
the record level of female life expectancy in the world. Then, to forecast male life 
expectancy, the gap between male life expectancy and female life expectancy in a 
country is analysed. The authors present results for various developed countries and 
compare their results with forecasts based on the Lee-Carter and Cairns-Blake-Dowd 
models, focusing on forecasting life expectancy at age 0 and remaining life expectancy at 
age 65. 
 
In ‘Mortality Models and Longevity Risk for Small Populations’, Jack C. Yue, Hsin Chung 
Wang and Chen-Tai Chong argue that prolonging life expectancy and improving mortality 
rates is a common trend of the 21st century. Stochastic models, such as the Lee-Carter 
model, are a popular choice to deal with longevity risk. However, these mortality models 
often have unsatisfactory results in the case of small populations. Thus, quite a few 
modifications (such as approximation and maximal likelihood estimation) to the 
Lee-Carter have to be used for the case of small populations or missing observations. In 
this study, the authors propose an alternative approach to improve the performance of 
stochastic models. The proposed approach is a combination of data aggregation and 
mortality graduation. The authors first combine the historical data of a target population, 
treating it as the reference population, and use data graduation methods (Whittaker and 
partial standard mortality ratio) to stabilize the mortality estimates of the target 
population. They first evaluate whether the proposed method have smaller errors in 
mortality estimation than the Lee-Carter model in the case of small populations, and 
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explore if it is possible to reduce the bias of parameter estimates in the Lee-Carter model. 
They found that the proposed approach can improve the model fit of the Lee-Carter 
model when the population size is 200,000 or less. 
 
In ‘Identifiability, Cointegration and the Gravity Model’, Andrew Hunt and David Blake 
point out that the gravity model of Dowd et al. (2011b) was introduced in order to achieve 
coherent projections of mortality between two related populations. However, this model 
as originally formulated is not well-identified since it gives projections which depend on 
the arbitrary identifiability constraints imposed on the underlying mortality model when 
fitting it to data. In this paper, the authors discuss how the gravity model can be modified 
to give well-identified projections of mortality rates and how this result can be 
generalised to more complicated mortality models. 
 
Finally, in ‘Modeling Trend Processes in Parametric Mortality Models’, Matthias Börger 
and Johannes Schupp argue that parametric mortality models like those of Lee and Carter 
(1992), Cairns et al. (2006b), or Plat (2009a) typically include one or more 
time-dependent parameters. Often, a random walk with drift is used to project these 
parameters into the future. However, longer time series of historical mortality data often 
show patterns which a random walk with drift is highly unlikely to generate. In fact, 
historical mortality trends often appear to be trend stationary around piecewise linear 
trends with changing slopes over time (see, e.g., Sweeting (2011) or Li et al. (2011)). 
Periods of lower mortality improvements are followed by periods of higher 
improvements and vice versa. In this paper, the authors propose an alternative trend 
process which builds on the patterns observed in the historical data. Future trend changes 
occur randomly over time, and also the trend change magnitude is stochastic. 
Furthermore, they show how the parameters of this trend process, in particular the 
probability of observing a trend change in a certain year and the distribution for the trend 
change magnitude, can be estimated from historical data. They also outline how 
uncertainty in the parameter estimates can be accounted for and compare the trend 
process to other trend processes which have been proposed in the literature. 
 
 
Longevity 12 took place in Chicago on September 29–30, 2016. Longevity 13 took place in 
Taipei, Taiwan on September 21–22, 2017. The North American Actuarial Journal will 
publish a Special Issue of selected papers presented at both conferences. Longevity 14 will 
take place in Amsterdam on September 21–22, 2018 and Longevity 15 will take place in 
New York on September 19-20, 2019. 
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